Tenax Therapeutics, Inc.
TENX
Revenue
0.00
0.000.00%
3 Months ChangeAssets
10.62M
▼-3.84M▼-26.58%
3 Months ChangeLiabilities
1.74M
▼-289.74k▼-14.27%
3 Months ChangeFree Cash Flow
-1.73M
▲1.22M▲41.37%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-10-30
Form 8-K
ID: 0001654954-24-013505
2024-08-13
Form 10-Q
ID: 0001654954-24-010456
2024-08-13
Form 8-K
ID: 0001654954-24-010454
2024-08-12
Form 8-K
ID: 0001654954-24-010278
2024-08-06
Form 8-K
ID: 0001654954-24-009988
2024-06-13
Form 8-K
ID: 0001654954-24-007727
2024-05-14
Form 10-Q
ID: 0001654954-24-006228
2024-05-14
Form 8-K
ID: 0001654954-24-006131
2024-03-28
Form 8-K
ID: 0001654954-24-003775
2024-02-23
Form 8-K
ID: 0001654954-24-002134